Physician profile
George Wang
NPI 1851342828
$18,168.39
in general payments reported to CMS, 2019-2025
75 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,244 · 2020: $2,452 · 2021: $2,725 · 2022: $2,787 · 2023: $2,674 · 2024: $2,481 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,833 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,833.47 |
| Education | $127.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,512.94 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Abbvie INC. | $1,340.05 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Jazz Pharmaceuticals INC. | $1,260.41 | 2019-2025 | Xywav, Epidiolex |
| Novartis Pharmaceuticals Corporation | $1,258.18 | 2019-2025 | |
| Amgen INC. | $851.65 | 2019-2022 | |
| Lilly USA, LLC | $794.00 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Allergan, INC. | $785.46 | 2019-2022 | |
| Harmony Biosciences LLC | $686.04 | 2020-2025 | Wakix |
| Biogen, INC. | $631.46 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Lundbeck LLC | $561.17 | 2020-2025 | Vyepti, Rexulti |
| Pfizer INC. | $553.61 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $507.21 | 2019-2022 | |
| Genzyme Corporation | $500.93 | 2019-2023 | |
| Sk Life Science, INC. | $442.06 | 2020-2025 | |
| Emd Serono, INC. | $401.81 | 2019-2025 |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.